{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:41:07Z","timestamp":1770676867559,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,18]]},"DOI":"10.7759\/cureus.15089","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T13:18:33Z","timestamp":1621343913000},"source":"Crossref","is-referenced-by-count":3,"title":["Pneumococcal Bacteremia and Cryptococcal Meningitis Dual Infection in a Patient With Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Abdul","family":"Raheem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balram","family":"Rathish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00566","article-title":"The epigenome in multiple myeloma: impact on tumor cell plasticity and drug response","volume":"8","author":"De Smedt E","year":"2018","unstructured":"De Smedt E, Lui H, Maes K, De Veirman K, Menu E, Vanderkerken K, De Bruyne E. The epigenome in multiple myeloma: impact on tumor cell plasticity and drug response. Front Oncol. 2018, 8:566. 10.3389\/fonc.2018.00566","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar SK","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, et al.. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014, 28:1122-8. 10.1038\/leu.2013.313","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.23","article-title":"Improved long-term survival in multiple myeloma up to the age of 80 years","volume":"28","author":"Kristinsson SY","year":"2014","unstructured":"Kristinsson SY, Anderson WF, Landgren O. Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia. 2014, 28:1346-8. 10.1038\/leu.2014.23","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0100","article-title":"Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003","volume":"25","author":"Kristinsson SY","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bj\u00f6rkholm M. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol. 2007, 25:1993-9. 10.1200\/JCO.2006.09.0100","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.04.001","article-title":"Management of older adults with multiple myeloma","volume":"27","author":"Palumbo A","year":"2013","unstructured":"Palumbo A, Mina R. Management of older adults with multiple myeloma. Blood Rev. 2013, 27:133-42. 10.1016\/j.blre.2013.04.001","journal-title":"Blood Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson BM","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, et al.. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005, 23:9219-26. 10.1200\/JCO.2005.03.2086","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4079-3","article-title":"Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma","volume":"26","author":"Lavi N","year":"2018","unstructured":"Lavi N, Avivi I, Kra-Oz Z, Oren I, Hardak E. Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma. Support Care Cancer. 2018, 26:2425-31. 10.1007\/s00520-018-4079-3","journal-title":"Support Care Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark C","year":"2015","unstructured":"Blimark C, Holmberg E, Mellqvist UH, et al.. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015, 100:107-13. 10.3324\/haematol.2014.107714","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13934","article-title":"How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation","volume":"173","author":"Maschmeyer G","year":"2016","unstructured":"Maschmeyer G, Donnelly JP. How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2016, 173:179-89. 10.1111\/bjh.13934","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu192","article-title":"Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"26","author":"Maschmeyer G","year":"2015","unstructured":"Maschmeyer G, Carratal\u00e0 J, Buchheidt D, et al.. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015, 26:21-33. 10.1093\/annonc\/mdu192","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2006.07.001","article-title":"Cryptococcosis","volume":"20","author":"Chayakulkeeree M","year":"2006","unstructured":"Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006, 20:507-44, v-vi. 10.1016\/j.idc.2006.07.001","journal-title":"Infect Dis Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00021-11","article-title":"Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance","volume":"18","author":"Karlsson J","year":"2011","unstructured":"Karlsson J, Andr\u00e9asson B, Kondori N, Erman E, Riesbeck K, Hogevik H, Wenner\u00e5s C. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance. Clin Vaccine Immunol. 2011, 18:969-77. 10.1128\/CVI.00021-11","journal-title":"Clin Vaccine Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.48.3.260","article-title":"Immunological factors and risk of infection in plateau phase myeloma","volume":"48","author":"Hargreaves RM","year":"1995","unstructured":"Hargreaves RM, Lea JR, Griffiths H, et al.. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol. 1995, 48:260-6. 10.1136\/jcp.48.3.260","journal-title":"J Clin Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.06.006","article-title":"Vaccination in multiple myeloma: review of current literature","volume":"16","author":"Alemu A","year":"2016","unstructured":"Alemu A, Richards JO, Oaks MK, Thompson MA. Vaccination in multiple myeloma: review of current literature. Clin Lymphoma Myeloma Leuk. 2016, 16:495-502. 10.1016\/j.clml.2016.06.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-013-9476-1","article-title":"Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study","volume":"29","author":"Carlson RD","year":"2014","unstructured":"Carlson RD, Rolfes MA, Birkenkamp KE, Nakasujja N, Rajasingham R, Meya DB, Boulware DR. Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study. Metab Brain Dis. 2014, 29:269-7. 10.1007\/s11011-013-9476-1","journal-title":"Metab Brain Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day JN","year":"2013","unstructured":"Day JN, Chau TTH, Wolbers M, et al.. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013, 368:1291-302. 10.1056\/NEJMoa1110404","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8040613","article-title":"New approaches for cryptococcosis treatment","volume":"8","author":"Spadari CC","year":"2020","unstructured":"Spadari CC, Wirth F, Lopes LB, Ishida K. New approaches for cryptococcosis treatment. Microorganisms. 2020, 8:613. 10.3390\/microorganisms8040613","journal-title":"Microorganisms"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic T","year":"2007","unstructured":"Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, Harrison T. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007, 45:76-80. 10.1086\/518607","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/58816-pneumococcal-bacteremia-and-cryptococcal-meningitis-dual-infection-in-a-patient-with-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:32Z","timestamp":1707507212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/58816-pneumococcal-bacteremia-and-cryptococcal-meningitis-dual-infection-in-a-patient-with-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.15089","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}